Company intelligence / Profile preview

RealTime Laboratories

Ownership: Private
Employees: ~33
Development stage: Commercial

Overview

RealTime Laboratories provides CAP-accredited and CLIA-certified clinical and environmental diagnostic testing focused on detecting hazardous molds and mycotoxins. Their comprehensive panels test for up to sixteen common toxic mycotoxins using advanced ELISA technology. They are recognized leaders in the field with published research contributions. No drug development or therapeutic clinical results apply.

Therapeutic areas: PulmonologyImmunologyInfectious Diseases
Modalities: Device (diagnostic kits)Molecular diagnostics (ELISA-based assays)DNA-based diagnostics
Industry: Molecular Diagnostics

Partnerships

Evexia Diagnostics

Beyond the preview

Go deeper on RealTime Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RealTime Laboratories.

Explore the full profile